Kither Biotech Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $6.35M
Latest Deal Amount
  • Investors
  • 11

Kither Biotech General Information

Description

Developer of anticancer and anti inflammation drugs intended to treat chronic inflammatory diseases. The company's drugs are researched for the treatment of cystic fibrosis, a disease that predominantly affects the lungs and is inline to create medication for the cure of chronic obstructive pulmonary diseases and allergic asthma, enabling patients with a treatment for their incurable respiratory diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • Via Nizza 52
  • 10126 Turin
  • Italy
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Kither Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 26-Jul-2019 $6.35M 00.000 000.00 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Kither Biotech’s complete valuation and funding history, request access »

Kither Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000 00.000000 000.00 000.00 00 000.00 00.000
To view Kither Biotech’s complete cap table history, request access »

Kither Biotech Executive Team (5)

Name Title Board Seat Contact Info
Marco Malisani Co-Founder & Chief Executive Officer
Emilio Hirsch Co-Founder & Chief Scientific Officer
Gian Tron Executive
Alberto Bardelli Co-Founder
Carla Uslenghi Chief Medical Officer
To view Kither Biotech’s complete executive team members history, request access »

Kither Biotech Board Members (4)

Name Representing Role Since
Laura Ferro Self Chairman 000 0000
Pietro Puglisi Claris Ventures Board Member 000 0000
Svetlana Vashkel CDP Venture Capital Board Member 000 0000
Vincent Metzler Ph.D Self Board Member 000 0000
To view Kither Biotech’s complete board members history, request access »

Kither Biotech Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ace Ventures Venture Capital Minority 000 0000 000000 0
B-Engine Venture Capital Minority 000 0000 000000 0
CDP Venture Capital Venture Capital Minority 000 0000 000000 0
Claris Ventures Venture Capital Minority 000 0000 000000 0
Club degli investitori Angel Group Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »